Cancers (Sep 2022)

Feasibility, Method and Early Outcome of Image-Guided Volumetric Modulated Arc Radiosurgery Followed by Resection for AJCC Stage IIA–IIIB High-Risk Large Intraocular Melanoma

  • Maja Guberina,
  • Ekaterina Sokolenko,
  • Nika Guberina,
  • Sami Dalbah,
  • Christoph Pöttgen,
  • Wolfgang Lübcke,
  • Frank Indenkämpen,
  • Manfred Lachmuth,
  • Dirk Flühs,
  • Ying Chen,
  • Christian Hoffmann,
  • Cornelius Deuschl,
  • Leyla Jabbarli,
  • Miltiadis Fiorentzis,
  • Andreas Foerster,
  • Philipp Rating,
  • Melanie Ebenau,
  • Tobias Grunewald,
  • Nikolaos Bechrakis,
  • Martin Stuschke

DOI
https://doi.org/10.3390/cancers14194729
Journal volume & issue
Vol. 14, no. 19
p. 4729

Abstract

Read online

The main objective of this prospective observational study was the characterization of the feasibility and early outcome of image-guided (IG) volumetric modulated arc (VMAT) radiosurgery (SRS) followed by resection for patients with large intraocular melanoma. Our study included consecutive patients with unfavorable-risk melanoma, enrolled in an ophthalmic oncology center. IG-VMAT-SRS was applied by high-resolution 4D image guidance and monitoring. Current stereotactic technique parameters were evaluated for comparison. Side effects and eye function, based on a 5-point CTC assessment score, were quantified. In patients with tumors located more than 0.7–1 mm apart from the optic nerve, partial to complete volume-sparing of the optic nerve head could be achieved. In 95.5% of this subgroup, the vitality of the optic nerve and vision could be preserved by the multimodality-treatment approach (mean follow-up: 18 months (7.5–36 months)). The advanced technology of stereotactic radiotherapy demonstrated the achievability of steep dose gradients around the high-dose volume, with 4D-IG-VMAT dose application. These results enforce IG-VMAT-SRS followed by resection as one of the major therapeutic options for patients with large intraocular melanoma. The combination of 4D-IG high-precision SRS and resection provides an effective treatment for large intraocular melanoma, with few side effects, and enables an eye bulb and even vision preserving modus operandi.

Keywords